Profarma Distribuidora de Produtos Farmacêuticos Past Earnings Performance
Past criteria checks 2/6
Profarma Distribuidora de Produtos Farmacêuticos has been growing earnings at an average annual rate of 35.5%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 15% per year. Profarma Distribuidora de Produtos Farmacêuticos's return on equity is 5.1%, and it has net margins of 0.8%.
Key information
35.5%
Earnings growth rate
35.6%
EPS growth rate
Healthcare Industry Growth | 11.6% |
Revenue growth rate | 15.0% |
Return on equity | 5.1% |
Net Margin | 0.8% |
Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) 28% Price Boost Is Out Of Tune With Earnings
Mar 01These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Feb 21Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)
Nov 04Investors Will Want Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Growth In ROCE To Persist
Aug 03These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Jun 08These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Sep 26Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Shares Fly 26% But Investors Aren't Buying For Growth
Jan 01Here's Why Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Weighed Down By Its Debt Load
May 28Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Might Have The Makings Of A Multi-Bagger
May 07How Much Of Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Do Institutions Own?
Mar 10Are Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 02Is Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Using Too Much Debt?
Jan 05What Type Of Shareholders Make Up Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) Share Registry?
Dec 10Revenue & Expenses BreakdownBeta
How Profarma Distribuidora de Produtos Farmacêuticos makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 8,662 | 70 | 1,046 | 0 |
30 Sep 23 | 8,550 | 47 | 875 | 0 |
30 Jun 23 | 8,291 | 31 | 843 | 0 |
31 Mar 23 | 8,087 | 82 | 814 | 0 |
31 Dec 22 | 7,816 | 81 | 917 | 0 |
30 Sep 22 | 7,435 | 87 | 754 | 0 |
30 Jun 22 | 7,031 | 96 | 730 | 0 |
31 Mar 22 | 6,661 | 63 | 691 | 0 |
31 Dec 21 | 6,413 | 78 | 667 | 0 |
30 Sep 21 | 6,199 | 95 | 644 | 0 |
30 Jun 21 | 5,891 | 99 | 608 | 0 |
31 Mar 21 | 5,579 | 60 | 580 | 0 |
31 Dec 20 | 5,481 | 52 | 568 | 0 |
30 Sep 20 | 5,281 | 44 | 554 | 0 |
30 Jun 20 | 5,218 | 16 | 561 | 0 |
31 Mar 20 | 5,104 | 21 | 568 | 0 |
31 Dec 19 | 4,801 | 12 | 555 | 0 |
30 Sep 19 | 4,677 | -5 | 568 | 0 |
30 Jun 19 | 4,513 | -13 | 581 | 0 |
31 Mar 19 | 4,388 | -12 | 590 | 0 |
31 Dec 18 | 4,271 | -10 | 606 | 0 |
30 Sep 18 | 4,066 | -37 | 611 | 0 |
30 Jun 18 | 4,009 | -65 | 615 | 0 |
31 Mar 18 | 4,046 | -91 | 636 | 0 |
31 Dec 17 | 4,101 | -113 | 653 | 0 |
30 Sep 17 | 4,223 | -126 | 648 | 0 |
30 Jun 17 | 4,195 | -100 | 611 | 0 |
31 Mar 17 | 4,149 | -67 | 561 | 0 |
31 Dec 16 | 4,085 | -49 | 505 | 0 |
30 Sep 16 | 3,858 | -18 | 445 | 0 |
30 Jun 16 | 3,780 | -14 | 415 | 0 |
31 Mar 16 | 3,619 | -23 | 387 | 0 |
31 Dec 15 | 3,465 | -21 | 358 | 0 |
30 Sep 15 | 3,471 | -34 | 355 | 0 |
30 Jun 15 | 3,392 | -48 | 348 | 0 |
31 Mar 15 | 3,430 | -46 | 353 | 0 |
31 Dec 14 | 3,449 | -52 | 364 | 0 |
30 Sep 14 | 3,439 | -37 | 379 | 0 |
30 Jun 14 | 3,455 | -11 | 370 | 0 |
31 Mar 14 | 3,456 | 0 | 353 | 0 |
31 Dec 13 | 3,470 | 20 | 333 | 0 |
30 Sep 13 | 3,453 | 33 | 295 | 0 |
30 Jun 13 | 3,394 | 38 | 284 | 0 |
Quality Earnings: PFRM3 has high quality earnings.
Growing Profit Margin: PFRM3's current net profit margins (0.8%) are lower than last year (1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PFRM3 has become profitable over the past 5 years, growing earnings by 35.5% per year.
Accelerating Growth: PFRM3's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PFRM3 had negative earnings growth (-13%) over the past year, making it difficult to compare to the Healthcare industry average (38.6%).
Return on Equity
High ROE: PFRM3's Return on Equity (5.1%) is considered low.